ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,509,420 | -60.7% | 203,000 | -55.5% | 0.21% | -60.0% |
Q2 2023 | $14,026,201 | +4002.6% | 456,285 | +5174.4% | 0.53% | +2833.3% |
Q4 2022 | $341,887 | +17.9% | 8,651 | +19.9% | 0.02% | +63.6% |
Q3 2022 | $290,000 | -25.8% | 7,215 | -26.4% | 0.01% | -56.0% |
Q4 2021 | $391,000 | – | 9,806 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |